The New England Journal of Medicine (NEJM) also reported in August 2020 about the bi-directional relationship between Covid-19 and diabetes. It is not uncommon for physicians to uncover new-onset diabetes, including ketosis-prone diabetes (worse form), sometimes transient rise after any acute illness or any infections. The complex pathophysiology of Covid-19 in altering glucose metabolism is being seen and being studied for the potential direct and independent diabetogenic effects of this virus.

Moderate to severe forms of COVID causes profound inflammation and subsequent damage to body organs, especially the lungs and more heart attacks and stroke, particularly in patients with diabetes, hypertension and heart disease. Treatment of confirmed moderate to severe COVID patients includes the use of steroids as part of clinical protocols to prevent or minimize inflammatory damage from the virus, particularly on the lung at an early or even late phase. Steroids can spike sugars besides increase appetite, causing increased calorie intake. Risk benefits outweigh the use of steroids if indicated during COVID or post-COVID lung damaged reduce inflammation of the lung. The magnitude of the hyperglycemic response and the duration of the effect depends on the dose and type of steroid.

Those COVID patients who have been administered Steroids during treatment do suffer from Raised Sugar Levels Post COVID. In this phase Glydor or Glynoma can be administered with Diapram Kadha.

Secondly if patient is Obese, start Swasthyam Diet Box / Prameha Diet box along with ample quantity of Salads, as Fiber Diet proves to be very effective in such cases.

Monitor patients properly & take a call till when this line of treatment needs to be continued.